{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:44:35Z","timestamp":1790063075936,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jogc.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jogc.2024.102730","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:32:11Z","timestamp":1732854731000},"page":"102730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Test or No-Test: Comparison of Medication Abortion Outcomes and Adverse Events When Forgoing Ultrasound, Laboratory Testing, and Physical Examination"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3366-8054","authenticated-orcid":false,"given":"Caitlin","family":"Hunter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Burck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Shawon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ruth","family":"Lavergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Whitten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-ling","family":"Wiedmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2024.102730_bib1","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/1471-0528.16668","article-title":"Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study","volume":"128","author":"Aiken","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2024.102730_bib2","article-title":"Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: a population based study","volume":"10","author":"Aiken","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"10.1016\/j.jogc.2024.102730_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.contraception.2021.07.108","article-title":"Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S","volume":"104","author":"Anger","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2024.102730_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0140-6736(22)01474-X","article-title":"A\u00a0telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial","volume":"400","author":"Endler","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2024.102730_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.contraception.2021.03.025","article-title":"Provision of medication abortion in Hawai\u2019I during COVID-19: practical experience with multiple care delivery models","volume":"104","author":"Kerestes","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2024.102730_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.contraception.2017.11.005","article-title":"Simplified medical abortion screening: a demonstration project","volume":"97","author":"Raymond","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2024.102730_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/bmjsrh-2020-200976","article-title":"Telemedicine medical abortion at home under 12 weeks\u2019 gestation: a prospective observational cohort study during the COVID-19 pandemic","volume":"47","author":"Reynolds-Wright","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"10.1016\/j.jogc.2024.102730_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/AOG.0000000000005016","article-title":"No-test medication abortion: a systematic review","volume":"141","author":"Pearlman Shapiro","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102730_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.22320","article-title":"Safety and efficacy of telehealth medication abortions in the US during the COVID-19 pandemic","volume":"4","author":"Upadhyay","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jogc.2024.102730_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamainternmed.2022.0217","article-title":"Outcomes and safety of history-based screening for medication abortion: a retrospective multicenter cohort study","volume":"182","author":"Upadhyay","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jogc.2024.102730_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.conx.2020.100023","article-title":"Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol","volume":"2","author":"Wiebe","year":"2020","journal-title":"Contracept X"},{"key":"10.1016\/j.jogc.2024.102730_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2010.02753.x","article-title":"Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone\u2013misoprostol","volume":"118","author":"Bracken","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2024.102730_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2014.07.004","article-title":"The accuracy of using last menstrual period to determine gestational age for first trimester medication abortion: a systematic review","volume":"90","author":"Schonberg","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2024.102730_bib14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2015.04.008","article-title":"Early medical abortion without prior ultrasound","volume":"92","author":"Raymond","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2024.102730_bib15","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/tmj.2022.0245","article-title":"Telemedicine for first-trimester medical abortion in Canada: results of a 2019 survey","volume":"29","author":"Renner","year":"2023","journal-title":"Telemed J E Health"},{"key":"10.1016\/j.jogc.2024.102730_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.conx.2020.100049","article-title":"Adoption of no-test and telehealth medication abortion care among independent abortion providers in response to COVID-19","volume":"2","author":"Upadhyay","year":"2020","journal-title":"Contraception. X"},{"key":"10.1016\/j.jogc.2024.102730_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2021.04.010","article-title":"Changes to medication abortion clinical practices in response to the COVID-19 pandemic","volume":"104","author":"Tschann","year":"2021","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2024.102730_bib18","series-title":"Induced abortion: updated guidance during pandemics and periods of social disruption","author":"Costescu","year":"2020"},{"key":"10.1016\/j.jogc.2024.102730_bib19","author":"Guilbert","year":"2020"},{"key":"10.1016\/j.jogc.2024.102730_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.contraception.2020.04.005","article-title":"Commentary: no-test medication abortion: a sample protocol for increasing access during a pandemic and beyond","volume":"101","author":"Raymond","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2024.102730_bib21","series-title":"Coronavirus (COVID-19) infection and abortion care","author":"Lord","year":"2020"},{"issue":"Suppl 1","key":"10.1016\/j.jogc.2024.102730_bib22","doi-asserted-by":"crossref","first-page":"i30","DOI":"10.1093\/fampra\/cmab083","article-title":"The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic","volume":"38","author":"Ennis","year":"2021","journal-title":"Fam Pract"},{"key":"10.1016\/j.jogc.2024.102730_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.jogc.2024.102730_bib24","unstructured":"L. StataCorp, Stata statistical software, release 15 college station: TX: StataCorp LP, 5, 2013, 231\u2013239. Available at https:\/\/www.socscistatistics.com\/tests\/chisquare2\/default2.aspx. Accessed 5 September 2023."},{"key":"10.1016\/j.jogc.2024.102730_bib25","author":"Stangroom"},{"key":"10.1016\/j.jogc.2024.102730_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110055","article-title":"Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine","volume":"124","author":"Anger","year":"2023","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2024.102730_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.contraception.2022.02.005","article-title":"Efficacy of a low-sensitivity urine\u00a0pregnancy test for identifying ongoing pregnancy after medication\u00a0abortion at 64 to 70 days of gestation","volume":"110","author":"Whitehouse","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2024.102730_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41746-023-00871-2","article-title":"Medication abortion via digital health in the United States: a systematic scoping review","volume":"6","author":"Kumsa","year":"2023","journal-title":"npj Digit Med"},{"key":"10.1016\/j.jogc.2024.102730_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jogc.2020.08.008","article-title":"A\u00a0retrospective cost-effectiveness analysis of mifepristone\u2013misoprostol medical abortions in the first year at the Regina General Hospital","volume":"43","author":"Hunter","year":"2021","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2024.102730_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.109996","article-title":"An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States","volume":"122","author":"Rosenberg","year":"2023","journal-title":"Contraception"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121632400553X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S170121632400553X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T12:57:59Z","timestamp":1737637079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S170121632400553X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S170121632400553X"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102730","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Test or No-Test: Comparison of Medication Abortion Outcomes and Adverse Events When Forgoing Ultrasound, Laboratory Testing, and Physical Examination","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author. Published by ELSEVIER INC. on behalf of The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada.","name":"copyright","label":"Copyright"}],"article-number":"102730"}}